Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations

被引:0
|
作者
Jesse J. Salk
Michael W. Schmitt
Lawrence A. Loeb
机构
[1] University of Washington School of Medicine,Department of Pathology
[2] University of Washington School of Medicine,Department of Medicine, Divisions of Hematology and Medical Oncology
[3] University of Washington School of Medicine,Department of Biochemistry
[4] Fred Hutchinson Cancer Research Center,Clinical Research Division
来源
Nature Reviews Genetics | 2018年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The ability to identify low-frequency genetic variants among heterogeneous populations of cells or DNA molecules is important in many fields of basic science, clinical medicine and other applications, yet current high-throughput DNA sequencing technologies have an error rate between 1 per 100 and 1 per 1,000 base pairs sequenced, which obscures their presence below this level.As next-generation sequencing technologies evolved over the decade, throughput has improved markedly, but raw accuracy has remained generally unchanged. Researchers with a need for high accuracy developed data filtering methods and incremental biochemical improvements that modestly improve low-frequency variant detection, but background errors remain limiting in many fields.The most profoundly impactful means for reducing errors, first developed approximately 7 years ago, has been the concept of single-molecule consensus sequencing. This entails redundant sequencing of multiple copies of a given specific DNA molecule and discounting of variants that are not present in all or most of the copies as likely errors.Consensus sequencing can be achieved by labelling each molecule with a unique molecular barcode before generating copies, which allows subsequent comparison of these copies or schemes whereby copies are physically joined and sequenced together. Because of trade-offs in cost, time and accuracy, no single method is optimal for every application, and each method should be considered on a case-by-case basis.Major applications for high-accuracy DNA sequencing include non-invasive cancer diagnostics, cancer screening, early detection of cancer relapse or impending drug resistance, infectious disease applications, prenatal diagnostics, forensics and mutagenesis assessment.Future advances in ultra-high-accuracy sequencing are likely to be driven by an emerging generation of single-molecule sequencers, particularly those that allow independent sequence comparison of both strands of native DNA duplexes.
引用
收藏
页码:269 / 285
页数:16
相关论文
共 50 条
  • [1] Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations
    Salk, Jesse J.
    Schmitt, Michael W.
    Loeb, Lawrence A.
    NATURE REVIEWS GENETICS, 2018, 19 (05) : 269 - 285
  • [2] Detection of Rare and Subclonal Mutations by Next-Generation Sequencing.
    Jesse, Salk
    Valentine, C. C.
    Loeb, L. A.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2018, 59 : 56 - 56
  • [3] Detection of ultra-rare mutations by next-generation sequencing
    Schmitt, Michael W.
    Kennedy, Scott R.
    Salk, Jesse J.
    Fox, Edward J.
    Hiatt, Joseph B.
    Loeb, Lawrence A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (36) : 14508 - 14513
  • [4] Comparing exome with wholegenome next-generation sequencing in detecting somatic mutations
    Yue, Yong Gang
    Ting, Jason
    Ma, Xiwen
    Barber, Thomas D.
    CANCER RESEARCH, 2012, 72
  • [5] Next-generation sequencing for detecting thyroid cancer
    Carol Wilson
    Nature Reviews Endocrinology, 2013, 9 (12) : 690 - 690
  • [6] Methods to improve the accuracy of next-generation sequencing
    Cheng, Chu
    Fei, Zhongjie
    Xiao, Pengfeng
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [7] Next-generation sequencing for rare genetic disorders
    Tekin, Mustafa
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S19 - S19
  • [8] Sensitivity and Limit of Detection of Next-Generation Sequencing for Detecting Somatic Mutations in Heterogeneous Samples
    Spencer, D.
    Vallania, F.
    Sehn, J. K.
    Mitra, R. D.
    Duncavage, E. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 732 - 732
  • [9] Detecting Clinically Actionable Mutations in Leukemia Using a Novel Targeted Next-Generation Sequencing Panel
    Chang, F.
    Liu, L.
    Fang, E.
    Zhang, G.
    Li, Y.
    Li, M. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 869 - 869
  • [10] Next-generation sequencing of the next generation
    Darren J. Burgess
    Nature Reviews Genetics, 2011, 12 : 78 - 79